secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inogen Inc (INGN)
CIK:        0001294133
Form:       8-K
Filed at:   2023-05-04T23:59:59+00:00
Accession:  0000950170-23-017865
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inogen Q1 2023 revenue $72.2M, net loss $20.3M; sees positive adjusted EBITDA by Q4 2023
--------------------------------------------------------------------------------

- Total revenue $72.2M, down 10.2% YoY; rental revenue up 25.4% YoY.
- GAAP net loss $20.3M vs $14.2M loss in Q1 2022; adjusted net loss $14.5M vs $8.7M.
- Adjusted EBITDA loss $11.8M vs $5.0M loss; expects positive adjusted EBITDA by Q4 2023.
- Cash and marketable securities $174.6M; no debt outstanding.
- Notified of France reimbursement for Rove 6; added two large private payers covering ~160M lives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1294133/000095017023017865/0000950170-23-017865-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1294133/000095017023017865/ingn-20230504.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-017865

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer